Impact of single-dose nilotinib on the pharmacokinetic and pharmacodynamic profiles of single-dose warfarin in fed volunteers
Latest Information Update: 03 May 2011
At a glance
- Drugs Nilotinib (Primary) ; Warfarin
- Indications Cancer; Thrombosis
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Novartis; Parexel International
Most Recent Events
- 03 May 2011 New trial record
- 01 Mar 2011 Results published in Clinical Drug Investigation.